← Eichor
Condition: Iodine Resistant Thyroid Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Iodine Resistant Thyroid Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06632860Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differenti
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07092514
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.